ALVOW - Alvotech


1.28
-0.110   -8.594%

Share volume: 3,222
Last Updated: 04-28-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.12%

PREVIOUS CLOSE
CHG
CHG%

$1.39
-0.11
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
-7.91%
1 Month
-15.23%
3 Months
-50.39%
6 Months
-57.62%
1 Year
-60.62%
2 Year
-42.08%
Key data
Stock price
$1.28
P/E Ratio 
0.00
DAY RANGE
$1.05 - $1.28
EPS 
N/A
52 WEEK RANGE
$1.03 - $4.99
52 WEEK CHANGE
-$60.49
MARKET CAP 
2.854 B
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.05
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,199
AVERAGE 30 VOLUME 
$3,246
Company detail
CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

N/A

Recent news
loading